However, the sample size is limited and the finer mechanism by which miR-98 and negatively regulated HMGA2 inhibits breast cancer cell proliferation, invasion, migration, invasion as well as the promotion of cell apoptosis requires further investigation, which may help identify a novel treatment target for breast cancer. Here, HMGA2 is linked to breast cancer.